Access the full text.
Sign up today, get DeepDyve free for 14 days.
B. Spiess, B. Braverman, A. Woronowicz, A. Ivankovich (1986)
Protection from cerebral air emboli with perfluorocarbons in rabbits.Stroke, 17 6
J. Cwajg, F. Xie, E. O’Leary, D. Kricsfeld, H. Dittrich, T. Porter (2000)
Detection of angiographically significant coronary artery disease with accelerated intermittent imaging after intravenous administration of ultrasound contrast material.American heart journal, 139 4
P. Keipert, N. Faithfull, JoAnn Bradley, Diane Hazard, James Hogan, M. Levisetti, Richard Peters (1994)
Oxygen delivery augmentation by low-dose perfluorochemical emulsion during profound normovolemic hemodilution.Advances in experimental medicine and biology, 345
Y. Kuroda, A. Morita, Y. Fujino, Y. Tanioka, K. Hiraoka, Y. Suzuki, Y. Ku, Y. Saitoh (1994)
Successful 48-hour preservation of ischemically damaged canine pancreas by the two-layer (UW solution/perfluorochemical) method.Transplantation proceedings, 26 2
P. Grayburn, James Weiss, T. Hack, E. Klodas, J. Raichlen, M. Vannan, Allan Klein, D. Kitzman, S. Chrysant, Jerald Cohen, D. Abrahamson, E. Foster, J. Pérez, G. Aurigemma, J. Panza, M. Picard, B. Byrd, D. Segar, Stuart Jacobson, D. Sahn, A. DeMaria (1998)
Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms.Journal of the American College of Cardiology, 32 1
E. Wei, R. Randad, Joseph Levasseur, Donald Abraham, H. Kontos (1993)
Effect of local change in O2 saturation of hemoglobin on cerebral vasodilation from hypoxia and hypotension.The American journal of physiology, 265 4 Pt 2
M. Forman, C. Pitarys, H. Vildibill, T. Lambert, D. Ingram, R. Virmani, J. Murray (1992)
Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion.Journal of the American College of Cardiology, 19 1
T. Floyd, A. Boroughs, C. Garvey, J. Dasher, C. Ikeda, H. Sloviter, M. Ziegler (1987)
Intestinal ischemia: treatment by peritoneal lavage with oxygenated perfluorochemical.Journal of pediatric surgery, 22 12
A. Baba, Y. Kim, H. Zhang, M. Liu, Arthur Slutsky (2000)
Perfluorocarbon blocks tumor necrosis factor‐α‐induced interleukin‐8 release from alveolar epithelial cells in vitroCritical Care Medicine, 28
S. Martin, H. Laks, D. Drinkwater, D. Stein, E. Capouya, J. Pearl, S. Barthel, P. Chang, E. Kaczer, S. Bhuta (1993)
Perfluorochemical reperfusion yields improved myocardial recovery after global ischemia.The Annals of thoracic surgery, 55 4
Onishchenko Na, Ivanitskiĭ Gr, Vazagashvili Mo, Maevskiĭ Ei, Zhukauskas GIu, Ilgiavichute IaS, Safonov Aa, Vorob'ev Si, Oranskaia Ga (1989)
Expediency of administration of fluorocarbon emulsion into the body of a cadaveric donor before taking the kidneys for transplantationVestnik khirurgii imeni I. I. Grekova, 143
R. Kline, W. Negendank, L. McCoy (1992)
Treatment of cerebral ischemia with Dextran-40 or Fluosol DA 20%.Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology, 20 2-4
K.K. Tremper, A.E. Freedman, E.M. Levine (1982)
The preoperative treatment of severely anemic patients with perfluorochemical emulsion oxygen transporting fluid, Fluosol-DAN Engl J Med, 307
Y. Oda, H. Handa, S. Nagasawa, Y. Naruo, R. Asato, Y. Yonekawa (1982)
Efficacy of a blood substitute (Fluosol-DA, 20%) on cerebral ischemia.Neurological research, 4 1-2
Y. Kuroda, T. Sakai, Yasuyuki Suzuki, Y. Tanioka, S. Matsumoto, Yongsik Kim, H. Fujita, M. Hamano, Y. Hasegawa, Y. Ku, Y. Saitoh (1995)
Small bowel preservation using a cavitary two-layer (University of Wisconsin solution/perfluorochemical) cold storage method.Transplantation, 61 3
R. Maughan, C. Mohan, I. Nathan, E. Ascer, P. Damiani, I. Jacobowitz, J. Cunningham, C. Marini (1992)
Intrathecal perfusion of an oxygenated perfluorocarbon prevents paraplegia after aortic occlusion.The Annals of thoracic surgery, 54 5
M. Perutz, C. Poyart (1983)
BEZAFIBRATE LOWERS OXYGEN AFFINITY OF HAEMOGLOBINThe Lancet, 322
Tamanna Nahar, Lori Croft, Robert Shapiro, Steven Fruchtman, Joseph Diamond, Milena Henzlova, Joseph Machac, Samantha Buckley, Martin Goldman (2000)
Comparison of four echocardiographic techniques for measuring left ventricular ejection fraction.The American journal of cardiology, 86 12
K. O'Donnell, M. Caty, S. Zheng, J. Rossman, R. Azizkhan (1997)
Oxygenated intraluminal perfluorocarbon protects intestinal muscosa from ischemia/reperfusion injury.Journal of pediatric surgery, 32 2
V. Mor-Avi, E. Caiani, K. Collins, C. Korcarz, J. Bednarz, R. Lang (2001)
Combined Assessment of Myocardial Perfusion and Regional Left Ventricular Function by Analysis of Contrast-Enhanced Power Modulation ImagesCirculation: Journal of the American Heart Association, 104
J. Kuvin, Jiefen Yao, P. Blomberg, N. Pandian (2000)
Identification of Viable Myocardium by Perfusion Imaging with Intravenous Contrast Echocardiography After Acute Myocardial InfarctionEchocardiography, 17
K. Bando, S. Teramoto, M. Tago, S. Seno, T. Murakami, S. Nawa, Y. Senoo (1988)
Oxygenated perfluorocarbon, recombinant human superoxide dismutase, and catalase ameliorate free radical induced myocardial injury during heart preservation and transplantation.The Journal of thoracic and cardiovascular surgery, 96 6
D. Spahn, K. Waschke, T. Standi, J. Motsch, M. Welte, L. Vanhuynegem, H. Gombotz, P. Coriat, P. Keipert (2001)
Oxygent™ reduces allogeneic blood transfusions in noncardiac surgery:a Phase 3 studyEuropean Journal of Anaesthesiology, 18
R. Noveck, E. Shannon, P. Leese, J. Shorr, K. Flaim, P. Keipert, C. Woods (2000)
Randomized Safety Studies of Intravenous Perflubron Emulsion. II. Effects on Immune Function in Healthy VolunteersAnesthesia & Analgesia, 91
R.P. Gehes, R.G. Monroe, K. Taylor (1968)
Survival of rats having red cells totally replaced with emulsified fluorocarbonFed Proc, 27
H. Anderson, P. Leimgruber, G. Roubin, D. Nelson, A. Gruentzig (1985)
Distal coronary artery perfusion during percutaneous transluminal coronary angioplasty.American heart journal, 110 4
Beverly Teicher (1995)
An overview on oxygen carriers in cancer therapy.Artificial cells, blood substitutes, and immobilization biotechnology, 23 3
S. Gould, A. Rosen, L. Sehgal, H. Sehgal, L. Langdale, L. Krause, C. Rice, W. Chamberlin, G. Moss (1986)
Fluosol-DA as a red-cell substitute in acute anemia.The New England journal of medicine, 315 26
K. Tremper, Alan Friedman, E. Levine, R. Lapin, Debra Camarillo (1982)
The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA.The New England journal of medicine, 307 5
Joachim Erb, J. Shanewise (2001)
Intraoperative contrast echocardiography with intravenous optison does not cause hemodynamic changes during cardiac surgery.Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 14 6
L. Zhao, J. Smith, C. Eyer (1995)
Effects of a 100% perfluorooctylbromide emulsion on ischemia/reperfusion injury following cardioplegia.Artificial cells, blood substitutes, and immobilization biotechnology, 23 4
W. Holman, R. Spruell, E. Ferguson, J. Clymer, W. Vicente, C. Murrah, A. Pacifico (1995)
Tissue oxygenation with graded dissolved oxygen delivery during cardiopulmonary bypass.The Journal of thoracic and cardiovascular surgery, 110 3
Taylor Tk, Bye Wa (1977)
Role of antibiotics in inflammatory disc lesions in children.The Lancet, 2
C. Poyart, M. Marden, J. Kister (1994)
Bezafibrate derivatives as potent effectors of hemoglobin.Methods in enzymology, 232
R. Cochran, K. Kunzelman, C. Vocelka, H. Akimoto, R. Thomas, L. Soltow, B. Spiess (1997)
Perfluorocarbon emulsion in the cardiopulmonary bypass prime reduces neurologic injury.The Annals of thoracic surgery, 63 5
Y. Oda, T. Murata, Y. Uchida, K. Mori, S. Nagasawa, Y. Naruo, R. Asato, H. Handa (1982)
[Clinical evaluation of artificial blood substitute (fluosol-DA 20%) in patients of cerebral ischemia].No shinkei geka. Neurological surgery, 10 6
K. Ohmori, B. Cotter, E. Leistad, V. Bhargava, P. Wolf, K. Mizushige, A. DeMaria (2001)
Assessment of Myocardial Postreperfusion Viability by Intravenous Myocardial Contrast Echocardiography: Analysis of the Intensity and Texture of OpacificationCirculation: Journal of the American Heart Association, 103
L. Segel, D. Follette, J. Iguidbashian, J. Contino, L. Castellanos, H. Berkoff, R. Kaufman, F. Schweighardt (1994)
Posttransplantation function of hearts preserved with fluorochemical emulsion.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 13 4
Prem Soman, J. Swinburn, Mathew Callister, Nigel Stephens, Roxy Senior (2001)
Apical hypertrophic cardiomyopathy: bedside diagnosis by intravenous contrast echocardiography.Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 14 4
Donald Abraham, Fred Wireko, R. Randad, C. Poyart, Jean Kister, Brigitte Bohn, Jean Liard, M. Kunert (1992)
Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats.Biochemistry, 31 38
A. Delrossi, A. Cernaianu, J. Cilley, R. Spence, R. Camishion, Y. Yu, J. Costabile, R. Vertrees (1990)
Preventive effect of Fluosol-DA for paraplegia encountered after surgical treatment of the thoracic aorta. Preliminary results in a dog model.The Journal of thoracic and cardiovascular surgery, 99 4
B. Bose, J. Osterholm, J. Payne, K. Chambers (1986)
Preservation of neuronal function during prolonged focal cerebral ischemia by ventriculocisternal perfusion with oxygenated fluorocarbon emulsion.Neurosurgery, 18 3
K. Kent, M. Cleman, M. Cowley, M. Forman, C. Jaffe, M. Kaplan, S. King, M. Krucoff, T. Lassar, B. McAuley (1990)
Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol.The American journal of cardiology, 66 3
K. Kilgore, C. Shwartz, M. Gallagher, R. Steffen, R. Mosca, S. Bolling (1999)
RSR13, a synthetic allosteric modifier of hemoglobin, improves myocardial recovery following hypothermic cardiopulmonary bypass.Circulation, 100 19 Suppl
Y. Kuroda, Y. Tanioka, A. Morita, K. Hiraoka, S. Matsumoto, Y. Fujino, K. Yamamoto, Y. Ku, Y. Saitoh (1994)
Protective effect of preservation of canine pancreas by the two-layer (University of Wisconsin solution/perfluorochemical) method against rewarming ischemic injury during implantation.Transplantation, 57 5
J. Wahr, A. Trouwborst, R. Spence, C. Henny, A. Cernaianu, G. Graziano, K. Tremper, K. Flaim, P. Keipert, N. Faithfull, Janice Clymer (1996)
A Pilot Study of the Effects of a Perflubron Emulsion, AF 0104, on Mixed Venous Oxygen Tension in Anesthetized Surgical PatientsAnesthesia & Analgesia, 82
Leland Clark, F. Gollan (1966)
Survival of Mammals Breathing Organic Liquids Equilibrated with Oxygen at Atmospheric PressureScience, 152
D. Spahn, R. Brempt, G. Theilmeier, J. Reibold, M. Welte, H. Heinzerling, Katrin Birck, P. Keipert, K. Messmer (1999)
Perflubron emulsion delays blood transfusions in orthopedic surgery. European Perflubron Emulsion Study Group.Anesthesiology, 91 5
J. Laycock, H. Coakham, I. Silver, F. Walters (1986)
Effect of carotid artery ligation and infusion of fluosol FC-43 emulsion on brain surface oxygen tensions.Stroke, 17 6
R. Spruell, E. Ferguson, J. Clymer, W. Vicente, C. Murrah, W. Holman (1995)
Perfluorocarbons are effective oxygen carriers in cardiopulmonary bypass.ASAIO journal, 41 3
P.T. Leese, R.J. Noveck, J.S. Shorr (2000)
Randomized safety studies of intravenous perflubron emulsion. I. Effects on coagulation function in healthy volunteersAnesthes Analg, 91
Joseph Watson, E. Doppenberg, M. Bullock, A. Zauner, Melody Rice, Donald Abraham, Harold Young (1997)
Effects of the allosteric modification of hemoglobin on brain oxygen and infarct size in a feline model of stroke.Stroke, 28 8
Denise Mcree, M. Matsuda, J. Stratton, G. Martin (1999)
Transthoracic contrast echocardiographic detection of ascending aortic dissection.Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 12 12
M. Cleman, C. Jaffee, D. Wohlgelernter (1986)
Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA 20%.Circulation, 74 3
J. Wahr, M. Gerber, J. Venitz, N. Baliga (2001)
Allosteric Modification of Oxygen Delivery by HemoglobinAnesthesia & Analgesia, 92
J. Briceño, T. Runge, J. Mcginity, S. Frisbee, S. Ottmers, D. Korvick, J. Calhoon, O. Miller, C. Hantler, Oran Cruzen, J. Ybarra, R. Howelton, Ruben Mireles, C. Benson (1997)
Changes in Brain pH, PO2, PCO2, Cerebral Blood Flow, and Blood Gases Induced by a Hyperosmolar Oxyreplete Hemosubstitute During Cardiopulmonary BypassASAIO Journal, 43
R. Randad, M. Mahran, A. Mehanna, D. Abraham (1991)
Allosteric modifiers of hemoglobin. 1. Design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents.Journal of medicinal chemistry, 34 2
J. Rossman, M. Caty, S. Zheng, H. Karamanoukian, K. Thusu, R. Azizkhan, P. Dandona (1997)
Mucosal protection from intestinal ischemia-reperfusion reduces oxidant injury to the lung.The Journal of surgical research, 73 1
R. Mosca, T. Rohs, R. Waterford, K. Childs, L. Brunsting, S. Bolling (1996)
Perfluorocarbon supplementation and postischemic cardiac function.Surgery, 120 2
K. Wei, A. Jayaweera, S. Firoozan, A. Linka, D. Skyba, S. Kaul (1998)
Basis for detection of stenosis using venous administration of microbubbles during myocardial contrast echocardiography: bolus or continuous infusion?Journal of the American College of Cardiology, 32 1
J. Stone, W. Piccione, L. Berrizbeitia, G. Dance, F. Schoen, R. Shemin, L. Cohn (1986)
Hemodynamic, metabolic, and morphological effects of cardiopulmonary bypass with a fluorocarbon priming solution.The Annals of thoracic surgery, 41 4
J. Briceño, I. Rincón, J. Vélez, I. Castro, M. Arcos, C. Velásquez (1999)
Oxygen transport and consumption during experimental cardiopulmonary bypass using oxyfluor.ASAIO journal, 45 4
B. Vocelka, MD Spiess, BS Soltow, BA Thomas, MD Gohra, MD Akimoto, C. Rothnie, PhD Kunzelman, MD Verrier, MD Cochran, Cardiothoracic Surgery (1995)
A perfluorocarbon emulsion prime additive improves the electroencephalogram and cerebral blood flow at the initiation of cardiopulmonary bypass.The journal of extra-corporeal technology, 27 1
Significant efforts have been made over the past 70 years to find a solution that could substitute for blood. Over the years, the focus has shifted to developing a solution capable of delivering oxygen to the tissues. Fluorocarbons (FC) are highly inert solutions with a high solubility for all gases, making them a prime candidate to become such an oxygen delivery agent. Although clinical research efforts into the use of these agents as substitutes for blood transfusions continue at present, the rapid disappearance of emulsified FCs from the vascular space and accumulation in the liver and spleen may well limit their usefulness as transfusion substitutes. Because of their ability to dissolve significant quantities of oxygen and carbon dioxide, these agents may be more attractive as oxygen delivery agents during periods of local or global organ ischemia, including preservation of organs for transplantation. FCs have also been tested in animal models of cardiopulmonary bypass, and may be efficacious in adsorbing the gases present in air emboli. Recently a second class of oxygen therapeutics (allosteric modifiers) has been developed, and these agents enhance oxygen delivery by shifting the oxygen dissociation curve to the right, thus increasing tissue PO2. Allosteric modifiers have been shown to effectively shift the p50 of hemoglobin 10mm Hg at clinically relevant dosages, and have been shown (in animal models) to reduce cerebral infarct size following carotid ligation and to improve myocardial performance following myocardial ischemia. Despite significant research efforts, however, none of the solutions under development are currently approved for clinical use by the Food and Drug Administration, with the exception of myocardial contrast imaging agents.
American Journal of Cardiovascular Drugs – Springer Journals
Published: Aug 17, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.